BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121850
Published online Oct 15, 2026. doi: 10.4251/wjgo.121850
Table 2 Survival outcomes based on Fusobacterium nucleatum expression in colorectal cancer
Outcome
Studies, n
Patients (low vs high), n
HR
95%CI
P value
RMST low (95%CI)
RMST high (95%CI)
RMST difference
RMST P value
Overall survival81091 (682 vs 409)0.990.82–1.200.9392.5 (87.18–96.9)91.4 (85.81–97.2)1.00.462
Disease-free survival31053 (572 vs 481)0.450.37–0.56< 0.001102.4 (99.0–105.9)80.5 (75.8–85.3)21.80.002
Cancer-specific survival4630 (185 vs 445)0.340.26–0.44< 0.00183.4 (77.0–90.0)45.0 (40.4–49.5)38.40.002


Write to the Help Desk